Bausch Health Companies | VRX - Current Liabilities



Bausch Health Companies reported $4.98B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Amgen USD 20.48B 2.53B Jun/2025
ANI Pharmaceuticals USD 236.83M 35.02M Jun/2025
Aurora Cannabis CAD 156.88M 7.07M Jun/2025
Bausch Health Companies USD 4.98B 719M Jun/2025
Biogen USD 3.18B 2.11B Jun/2025
Bristol-Myers Squibb USD 27.53B 3.46B Jun/2025
Canopy Growth CAD 98.67M 1.65M Jun/2025
Corcept Therapeutics USD 144.66M 1.6M Jun/2025
Danaher USD 6.79B 147M Jun/2025
Drreddys Laboratories INR 142.59B 10.64B Jun/2025
Eli Lilly USD 39.02B 8.95B Jun/2025
Gilead Sciences USD 11.19B 1.15B Jun/2025
Novo Nordisk 207.52B 28.6B Jun/2025
Pacira USD 313.16M 1.57M Jun/2025
Perrigo USD 1.13B 52.3M Jun/2025
Prestige Brands USD 109.67M 3.04M Jun/2025
Supernus Pharmaceuticals USD 286.36M 4.59M Jun/2025
Vertex Pharmaceuticals USD 4.14B 355.2M Jun/2025
Zoetis USD 3.37B 19M Jun/2025